Focused clinical campaign improves mineral and bone disorder outcomes

Journal of Renal Care

Volumn 38, Issue 1, 2012, Pages 2-8

  Benner, Debbie ^a   Nissenson, Allen R ^b   van Wyck, David ^b  

^a DaVita National Nutrition   (United States)

^b DAVITA INC   (United States)

Author keywords

KDOQI; MBD outcomes; MBD scorecard; Patient education; Team involvement

Indexed keywords

CALCIUM; MINERAL; PHOSPHORUS;

ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; FEMALE; HEALTH CARE QUALITY; HEALTH PROMOTION; HUMAN; MALE; METABOLIC BONE DISEASE; METHODOLOGY; PATIENT CARE; PATIENT EDUCATION; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

BONE DISEASES, METABOLIC; CALCIUM; FEMALE; HEALTH PROMOTION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MINERALS; PATIENT CARE TEAM; PATIENT EDUCATION AS TOPIC; PHOSPHORUS; PROGRAM EVALUATION; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 84857619191     PISSN: 17556678     EISSN: 17556686     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2012.00233.x     Document Type: Article

References (17)

1. Block G.A., Hulbert-Shearon T.E., Levin N.W. et al. (1998). Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. American Journal of Kidney Diseases 31, 607-617.
2. Block G.A. & Port F.K. (2000). Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. American Journal of Kidney Diseases 35, 1226-1237.
3. Block G.A., Klassen P.S., Lazarus J.M. et al. (2004). Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. Journal of American Society of Nephrology 15, 2208-2218.
4. Dawnay A., Farrington K., Castledine C. et al. (2010). Chapter 10: Biochemistry profile of patients receiving dialysis in the UK in 2008: national and centre-specific analyses. The UK Renal Registry 12th Annual Report, 187-237.
5. Ford J.C., Pope J.F., Hunt A.E. et al. (2004). The effect of diet education on the laboratory values and knowledge of hemodial-ysis patients with hyperphosphatemia. Journal of Renal Nutrition 14, 36-44.
6. Hruska K.A., Saab G., Mathew S. et al. (2007). Renal osteodystrophy, phosphate homeostasis, and vascular calcification. Seminars in Dialysis 20, 309-315.
7. Kalantar-Zadeh K., Kuwae N., Regidor D.L. et al. (2006). Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney International 70, 771-780.
8. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease (2003). American Journal of Kidney Diseases 42, S1-201.
9. Menon V., Greene T., Pereira A.A. et al. (2005). Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. American Journal of Kidney Diseases 46, 455-463.
10. Moe S., Drueke T., Cunningham J. et al. (2006). Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney disease: improving global outcomes (KDIGO). Kidney International 69, 1945-1953.
11. Rambod M., Bross R., Zitterkoph J. et al. (2009). Association of malnutrition-inflammation score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. American Journal of Kidney Diseases 53, 298-309.
12. Reddy V., Symes F., Sethi N. et al. (2009). Dietitian-led education program to improve phosphate control in a single-center hemodialysis population. Journal of Renal Nutrition 19, 314-320.
13. Saran R., Bragg-Gresham J.L., Rayner H.C. et al. (2003). Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney International 64, 254-262.
14. Schlatter S. & Ferrans C.E. (1998). Teaching program effects on high phosphorus levels in patients receiving hemodialysis. American Nephrology Nurses Association Journal 25, 31-36; discussion 37-38.
15. Shaw-Stuart N.J. & Stuart A. (2000). The effect of an educational patient compliance program on serum phosphate levels in patients receiving hemodialysis. Journal of Renal Nutrition 10, 80-84.
16. Tentori F., Blayney M.J., Albert J.M. et al. (2008). Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the dialysis outcomes and practice patterns study (DOPPS). American Journal of Kidney Diseases 52, 519-530.
17. Young E.W., Akiba T., Albert J.M. et al. (2004). Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). American Journal of Kidney Diseases 44, 34-38.